It came as a surprise to me, as it did for many others. My understanding of the situation is that neither the efficacy nor the safety of the Medicago vaccine were at issue. It was rather the company's links to a tobacco manufacturer.
The WHO position was known, and is defensible from a world health standpoint.
I believe that Medicago and the government will have to work with their financial partners to find a solution that would be acceptable to the WHO. They will have to ensure that the Medicago vaccine, which has yielded excellent results in clinical studies, obtains the approval of the WHO. The vaccine could then be used within the COVAX mechanism and distributed to countries that still need large supplies of vaccines. In Canada, there is less need, but it's still very important elsewhere on the planet.